Captrust Financial Advisors grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 9.7% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,816 shares of the medical device company’s stock after purchasing an additional 338 shares during the quarter. Captrust Financial Advisors’ holdings in Cooper Companies were worth $421,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ashton Thomas Securities LLC acquired a new position in shares of Cooper Companies during the 3rd quarter valued at about $25,000. Innealta Capital LLC acquired a new position in shares of Cooper Companies during the 2nd quarter valued at about $25,000. Covestor Ltd boosted its position in shares of Cooper Companies by 144.9% during the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock valued at $37,000 after acquiring an additional 200 shares during the last quarter. Crewe Advisors LLC boosted its position in shares of Cooper Companies by 286.4% during the 2nd quarter. Crewe Advisors LLC now owns 340 shares of the medical device company’s stock valued at $30,000 after acquiring an additional 252 shares during the last quarter. Finally, Tortoise Investment Management LLC boosted its position in shares of Cooper Companies by 75.4% during the 2nd quarter. Tortoise Investment Management LLC now owns 393 shares of the medical device company’s stock valued at $34,000 after acquiring an additional 169 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.
Wall Street Analyst Weigh In
Several research analysts have recently weighed in on COO shares. Stifel Nicolaus reissued a “buy” rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Robert W. Baird increased their target price on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a research note on Thursday, August 29th. Citigroup lowered their target price on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research note on Friday, December 6th. Morgan Stanley lowered their target price on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a research note on Friday, December 6th. Finally, Wells Fargo & Company increased their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Four equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $117.00.
Insider Activity at Cooper Companies
In other Cooper Companies news, CEO Albert G. White III sold 114,992 shares of the stock in a transaction that occurred on Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. This represents a 41.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. 2.00% of the stock is owned by corporate insiders.
Cooper Companies Stock Down 2.6 %
Shares of COO opened at $96.72 on Friday. The stock has a market capitalization of $19.26 billion, a PE ratio of 49.60, a P/E/G ratio of 2.17 and a beta of 0.97. The Cooper Companies, Inc. has a 1 year low of $84.76 and a 1 year high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The company’s 50-day simple moving average is $103.71 and its 200-day simple moving average is $98.87.
Cooper Companies (NASDAQ:COO – Get Free Report) last issued its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, beating the consensus estimate of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The firm’s revenue was up 9.8% compared to the same quarter last year. During the same quarter last year, the company earned $0.87 earnings per share. Analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.
Cooper Companies Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Further Reading
- Five stocks we like better than Cooper Companies
- Comparing and Trading High PE Ratio Stocks
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- Using the MarketBeat Dividend Yield Calculator
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- What Are Dividends? Buy the Best Dividend Stocks
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.